Sign In
Buy VTRS
$16.39
+0.120 (+0.738%)
At Close: Jul 13, 2026
Viatris Inc. (VTRS) Q4 2024 Earnings Call Transcript
11:51am, Thursday, 27'th Feb 2025
Viatris Inc. (NASDAQ:VTRS ) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET Company Participants Bill Szablewski - Head of Capital Markets Scott Smith - CEO Philippe Martin - Chief R&D O
Viatris: One Swallow Doesn't Make A Summer
10:52am, Thursday, 27'th Feb 2025
Viatris Inc. missed estimates on sales and earnings per share. The company's 2025 guidance reveals significant challenges, including a $385 million EBITDA hit from issues at the Indore plant. We would
Viatris Misses Estimates, Cash Flow Up
10:17am, Thursday, 27'th Feb 2025
Viatris (VTRS -16.15%), a global healthcare company known for its broad portfolio of pharmaceutical products, released its fourth-quarter 2024 results on Feb. 27. Despite achieving substantial debt re
Viatris (VTRS) Q4 Earnings and Revenues Lag Estimates
08:55am, Thursday, 27'th Feb 2025
Viatris (VTRS) came out with quarterly earnings of $0.54 per share, missing the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.61 per share a year ago.
Drugmaker Viatris forecasts weak 2025 results after import curbs on India plant
08:29am, Thursday, 27'th Feb 2025
Viatris forecast annual revenue and profit below Wall Street estimates on Thursday, two months after the U.S. health regulator restricted imports from one of the drugmaker's key plants in India.
Viatris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Financial Guidance
06:45am, Thursday, 27'th Feb 2025
PITTSBURGH , Feb. 27, 2025 /PRNewswire/ -- Meets 2024 Guidance for Total Revenues, Adjusted EBITDA and Adjusted EPS; Exceeds 2024 Guidance for Free Cash Flow [1] Reports 2024 Total Revenues of $14.7
Viatris Maintains Dividend Policy for 2025 and Announces Quarterly Dividend
06:30am, Thursday, 27'th Feb 2025
PITTSBURGH , Feb. 27, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that on February 24, 2025, its Board of Directors approved a 2025 dividend policy of 48 cents ($0.48) per sha
Idorsia and Viatris update their collaboration for selatogrel and cenerimod
12:55am, Wednesday, 26'th Feb 2025
Ad hoc announcement pursuant to Art. 53 LR Idorsia's contribution to the development costs reduced by USD 100 million Viatris potential regulatory and sales milestones payments to Idorsia reduced by U
What's in Store for These 5 Biotech Stocks This Earnings Season?
11:30am, Monday, 24'th Feb 2025
Let's look at five biotech and drug companies, VTRS, PRGO, NVAX, NTLA and IOVA, slated to release their fourth-quarter 2024 results on Feb. 27, 2025.
Stay Ahead of the Game With Viatris (VTRS) Q4 Earnings: Wall Street's Insights on Key Metrics
10:22am, Monday, 24'th Feb 2025
Beyond analysts' top -and-bottom-line estimates for Viatris (VTRS), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter
What's in the Cards for Viatris Stock This Q4 Earnings?
02:55pm, Friday, 21'st Feb 2025
VTRS' Q4 results are likely to gain from new product launches in all major geographies.
Earnings Preview: Viatris (VTRS) Q4 Earnings Expected to Decline
11:06am, Thursday, 20'th Feb 2025
Viatris (VTRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Viatris to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
04:30pm, Monday, 03'rd Feb 2025
PITTSBURGH , Feb. 3, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will report financial results for the fourth quarter and full year 2024 on Thursday, February 27, 2025. Company executives will
Viatris: Consolidate In 2025, Win In 2026 - How 'Phase 2' Of Business Plan May Play Out
05:25pm, Friday, 24'th Jan 2025
Viatris, formed from Mylan and Pfizer's Established Brands, has faced stock price volatility since its inception in 2020. I rated Viatris a "Buy" last October, based on management's completion of "Pha
Is Viatris (VTRS) a Great Value Stock Right Now?
10:46am, Wednesday, 15'th Jan 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
